Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: The multiethnic cohort study

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 125-134

  Woolcott, Christy G ^a   Shvetsov, Yurii B ^a   Stanczyk, Frank Z ^b   Wilkens, Lynne R ^a   White, Kami K ^a   Caberto, Christian ^a   Henderson, Brian E ^b   Marchand, Loïc Le ^a   Kolonel, Laurence N ^a   Goodman, Marc T ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRONE; ESTRONE SULFATE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; RANDOM SAMPLE;

AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CASE-CONTROL STUDIES; COHORT STUDIES; CULTURAL DIVERSITY; ETHNIC GROUPS; FEMALE; GONADAL STEROID HORMONES; HAWAII; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POPULATION; POSTMENOPAUSE; RISK FACTORS;

EID: 77449116626     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0211     Document Type: Article

References (43)

1. Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N & Hankinson SE 2006 Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). Journal of the National Cancer Institute 98 110-115.
2. Clemons M & Goss P 2001 Estrogen and the risk of breast cancer. New England Journal of Medicine 344 276-285.
3. Cummings SR, Duong T, Kenyon E, Cauley JA, Whitehead M & Krueger KA 2002 Serum estradiol level and risk of breast cancer during treatment with raloxifene. Journal of the American Medical Association 287 216-220.
4. Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM & Cauleys JA 2005 Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cancer Epidemiology, Biomarkers and Prevention 14 1047-1051.
5. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA & Schatzkin A 1996 Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 5 533-539.
6. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT & Kahle L 1997 Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3β, 17β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 6 177-181.
7. Eliassen AH, Missmer SA, Tworoger SS & Hankinson SE 2006 Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? Journal of Clinical Oncology 24 1823-1830.
8. Endogenous Hormones and Breast Cancer Collaborative Group 2003 Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute 95 1218-1226.
9. Geisler J 2003 Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. Journal of Steroid Biochemistry and Molecular Biology 86 245-253.
10. Goebelsmann U, Horton R, Mestman JH, Arce JJ, Nagata Y, Nakamura RM, Thorneycroft IH & Mishell DR Jr 1973 Male pseudohermaphroditism due to testicular 17-hydroxysteroid dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism 36 867-879.
11. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL et al. 2009 Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 101 48-60.
12. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL & Speizer FE 1998 Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 90 1292-1299.
13. Henderson BE & Feigelson HS 2000 Hormonal carcinogenesis. Carcinogenesis 21 427-433.
14. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT et al. 2005 Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocrine-Related Cancer 12 1071-1082.
15. Kabuto M, Akiba S, Stevens RG, Neriishi K & Land CE 2000 A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiology, Biomarkers and Prevention 9 575-579.
16. Key T, Appleby P, Barnes I & Reeves G 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute 94 606-616.
17. Kim MY & Zeleniuch-Jacquotte A 1997 Correcting for measurement error in the analysis of case-control data with repeated measurements of exposure. American Journal of Epidemiology 145 1003-1010.
18. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME & Nagamine FS 2000 A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. American Journal of Epidemiology 151 346-357.
19. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E et al. 2006 Comparison of methods to measure low serum estradiol levels in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 91 3791-3797.
20. Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A & Lenner P 2003 Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes and Control 14 599-607.
21. Mickey RM & Greenland S 1989 The impact of confounder selection criteria on effect estimation. American Journal of Epidemiology 129 125-137.
22. Missmer SA, Eliassen AH, Barbieri RL & Hankinson SE 2004 Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Journal of the National Cancer Institute 96 1856-1865.
23. Onland-Moret NC, Kaaks R, van Noord PA, Rinaldi S, Key T, Grobbee DE & Peeters PH 2003 Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. British Journal of Cancer 88 1394-1399.
24. Park SY, Murphy SP, Wilkens LR, Yamamoto JF, Sharma S, Hankin JH, Henderson BE & Kolonel LN 2005 Dietary patterns using the Food Guide Pyramid groups are associated with sociodemographic and lifestyle factors: the multiethnic cohort study. Journal of Nutrition 135 843-849.
25. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M & Maloche C 1996 Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 81 1460-1464.
26. Pike MC, Kolonel LN, Henderson BE, Wilkens LR, Hankin JH, Feigelson HS, Wan PC, Stram DO & Nomura AM 2002 Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiology, Biomarkers and Prevention 11 795-800.
27. Ranadive GN, Mistry JS, Damodaran K, Khosravi MJ, Diamandi A, Gimpel T, Castracane VD, Patel S & Stanczyk FZ 1998 Rapid, convenient radioimmuno-assay of estrone sulfate. Clinical Chemistry 44 244-249.
28. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Riboli E, Toniolo P & Kaaks R 2002 Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiology, Biomarkers and Prevention 11 1065-1071.
29. Setiawan VW, Haiman CA, Stanczyk FZ, Le ML & Henderson BE 2006 Racial/ethnic differences in post-menopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiology, Biomarkers and Prevention 15 1849-1855.
30. Shimizu H, Ross RK, Bernstein L, Pike MC & Henderson BE 1990 Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. British Journal of Cancer 62 451-453.
31. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G et al. 2009 Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiology, Biomarkers and Prevention 18 169-176.
32. Sodergard R, Backstrom T, Shanbhag V & Carstensen H 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. Journal of Steroid Biochemistry 16 801-810.
33. Stanczyk FZ, Lee JS & Santen RJ 2007 Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiology, Biomarkers and Prevention 16 1713-1719.
34. Stanczyk FZ, Slater CC, Ramos DE, Azen C, Cherala G, Hakala C, Abraham G & Roy S 2009 Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women. Menopause 16 272-278.
35. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P & Pasternack BS 1995 A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute 87 190-197.
36. Tworoger SS & Hankinson SE 2006 Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes & Control 17 889-899.
37. Vermeulen A, Verdonck L & Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 84 3666-3672.
38. Wang B, Mi M, Wang J, Wei N, Zhang Q, Zhu J, Yang S, Guo B, Xu J & Yang X 2009 Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing, China International Journal of Cancer 124 1892-1899.
39. Woolcott CG, Maskarinec G, Pike MC, Henderson BE, Wilkens LR & Kolonel LN 2009 Breast cancer risk and hysterectomy status: the Multiethnic Cohort study. Cancer Causes and Control 20 539-547.
40. Wu AH, Yu MC, Tseng CC, Stanczyk FZ & Pike MC 2009 Dietary patterns and breast cancer risk in Asian American women. American Journal of Clinical Nutrition 89 1145-1154.
41. Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD & Zheng W 2003 Plasma sex steroid hormones and breast cancer risk in Chinese women. International Journal of Cancer 105 92-97.
42. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, Pasternack BS & Toniolo P 1997 Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. American Journal of Epidemiology 145 1030-1038.
43. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmed-khanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks R & Toniolo P 2004 Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: longterm results of a prospective study. British Journal of Cancer 90 153-159.